Home>>Signaling Pathways>> GPCR/G protein>> Cannabinoid Receptor>>BML-190

BML-190 Sale

(Synonyms: 吲哚美辛吗啉代酰胺; Indomethacin morpholinylamide; IMMA) 目录号 : GC11376

A CB2 receptor inverse agonist

BML-190 Chemical Structure

Cas No.:2854-32-2

规格 价格 库存 购买数量
10mM (in 1mL DMSO)
¥450.00
现货
10mg
¥332.00
现货
50mg
¥1,080.00
现货
100mg
¥1,980.00
现货
500mg
¥6,750.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

Description

BML-190(IMMA) is a potent and selective CB2 receptor ligand (Ki values = 435 nM)

The cannabinoid receptor (CB1 and CB2) is a member of G-protein coupled receptor (GPCR) which plays a significant role in physiologic processes such as cognitive and immune functions.

In HEK-293 cells expressing human Cb2 receptor, BML-190 promoted the forskoline-stimulated accumulation of cAMP. BML-190 also reduced the basal level production of inositol phosphate the CB(2) receptor and 16z44-expressing cells. [1]

BML-190 played a role in LPS (lipopolysaccharide)-activated inflammation [2] and in lowering human cytokine secretion and monocytic cell neurotoxicity [3]. It activated fibroblastic colony formation [4] and moderated collagen-induce arthritis [5].

References:
[1] New DC, Wong YH.  BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates.  FEBS Lett. 2003 Feb 11;536(1-3):157-60.  PubMed PMID: 12586356.
[2] Chang YH, Lee ST, Lin WW.  Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.  J Cell Biochem.  2001;81(4):715-23. PubMed PMID: 11329626.
[3] Klegeris A, Bissonnette CJ, McGeer PL.  Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.  Br J Pharmacol. 2003 Jun;139(4):775-86. PubMed PMID: 12813001; PubMed Central PMCID: PMC1573900. 
[4] Scutt A, Williamson EM.  Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors.  Calcif Tissue Int. 2007 Jan;80(1):50-9.  Epub 2007 Jan 4. PubMed PMID: 17205329.
[5] Zhang L, Zhang X, Wu P, Li H, Jin S, Zhou X, Li Y, Ye D, Chen B, Wan J.  BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis.  Inflamm Res. 2008 Apr;57(4):157-62. doi: 10. 1007/s00011-007-7141-z. PubMed PMID: 18648754.
[6] Zhang Q, Ma P, Cole RB, Wang G.  In vitro metabolism of indomethacin morpholinylamide (BML-190), an inverse agonist for the peripheral cannabinoid receptor (CB(2)) in rat liver microsomes.  Eur J Pharm Sci. 2010 Sep 11;41(1):163-72.  doi: 10.1016/j.ejps.2010.06.004. Epub 2010 Jun 11. PubMed PMID: 20542112; PubMed Central PMCID: PMC2907062. 

化学性质

Cas No. 2854-32-2 SDF
别名 吲哚美辛吗啉代酰胺; Indomethacin morpholinylamide; IMMA
化学名 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-1-morpholin-4-ylethanone
Canonical SMILES CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)N4CCOCC4
分子式 C23H23ClN2O4 分子量 426.89
溶解度 ≥ 42.7mg/mL in DMSO with gentle warming 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 2.3425 mL 11.7126 mL 23.4252 mL
5 mM 0.4685 mL 2.3425 mL 4.685 mL
10 mM 0.2343 mL 1.1713 mL 2.3425 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

产品文档

Quality Control & SDS

View current batch: